Skip to main content

Table 2 Descriptions of the three reported cases which developed coronary artery disease during sorafenib treatment

From: Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib

Reference

Case

Disease

Types of events

Cardiovascolar risck factors

Coronarography

Naib T et al. [9]

57 years-old patient

HCC

multiple coronary vasospasm

history of diabetes, hyperlipidemia, former tobacco use

Normal

Arima Y et al. [10]

65 years-old patient

mRCC

coronary artery spasm

arterial hypertension

Normal

Porto I et al. [11]

63 years-old patient

HCC

variant angina for spontaneous coronary spasm

history of diabetes and arterial hypertension,

Normal